EPAM
BNR

Euro Pacific Asset Management’s Burning Rock Biotech BNR Stock Holding History

Euro Pacific Asset Management’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,741
Closed -$261K – 62
2021
Q4 		$261K Sell
2,741
-190
-6% -$26K 0.06% 57
2021
Q3 		$524K Buy
+2,931
New +$652K 0.14% 51

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Euro Pacific Asset Management's BNR Position: Q1 2022 in Review

Euro Pacific Asset Management sold out of Burning Rock Biotech (BNR) in Q1 2022, closing a stake of 2,741 shares — an estimated $261K sold.

Euro Pacific Asset Management first reported a position in BNR in Q3 2021 and held it in 2 quarters. The position peaked at $524K in Q3 2021. 46 funds tracked by Wall St. Rank hold BNR as of Q1 2022.

  • Euro Pacific Asset Management reported no remaining Burning Rock Biotech position as of Q1 2022 after selling out during the quarter.
  • Euro Pacific Asset Management sold 2,741 Burning Rock Biotech shares in Q1 2022, an estimated $261K.
  • Euro Pacific Asset Management first reported a position in Burning Rock Biotech in Q3 2021 and held it in 2 quarters.
  • Euro Pacific Asset Management's Burning Rock Biotech position peaked at $524K in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2022.

Based on Euro Pacific Asset Management's 13F filing for Q1 2022, filed 13 May 2022.